a1 Adrenergic receptors mediate a variety of physiological responses and have been well studied in the cardiovascular and peripheral nervous system. However, their role in the central nervous system remains ill defined because of the lack of highly specific ligands to the a1 receptor subtypes. Here, we have employed gene targeting to elucidate the role of a1d receptors in vivo. In addition to disrupting function, the insertion of the lacZ gene into the a1d receptor locus enabled the specific identification of cells expressing the a1d gene. These cells are localized in the cortex, hippocampus, olfactory bulb, dorsal geniculate and ventral posterolateral nuclei of the thalamus. Behaviorally, the a1d À/À mice show normal locomotor activity during the subjective day, or resting phase of their cycle. However, during subjective night, or active phase, wheel-running activity is significantly reduced in mutant mice. Furthermore, these mice show a reduction in exploratory rearing behavior in a novel cage environment. Lastly, a1d À/À mice show reduced hyperlocomotion after acute amphetamine administration. Together, these data reveal the functional importance of a1d adrenoceptors in mediating a variety of stimulus-induced changes in locomotor behaviors. While the sensitivity of noradrenergic neurons to environmental stimuli has been well documented, our data demonstrate that at least some of these post-synaptic responses are mediated by a1d adrenergic receptors. Molecular Psychiatry (2003) 8, 664-672. doi:10.1038/sj.mp.4001351
Adrenergic receptors mediate a variety of physiological responses including the regulation of cardiovascular function, glycogenolysis and the contractility of the urinary tract. These receptors are targets for norepinephrine and epinephrine and have been well studied in the peripheral nervous system. However, their role in the central nervous system (CNS) remains enigmatic. The noradrenergic system is important for numerous behavioral states, such as arousal, attention, vigilance and anxiety. [1] [2] [3] [4] Furthermore, activation of the noradrenergic system has been implicated in mediating responses induced specifically by changes in stimuli, such as exploratory behavior, arousal and circadian behavior. [5] [6] [7] [8] Noradrenergic activation may also be involved in locomotor and rewarding effects of drugs of abuse, such as psychostimulants and opiates. A variety of studies have documented the existence of interactions between ascending noradrenergic and dopaminergic systems. [9] [10] [11] [12] The mechanisms underlying these interactions appear to involve stimulation of a1 adrenergic receptors. [13] [14] [15] For example, injection of prazosin, a non-selective a1 antagonist prior to administration of D-amphetamine, reduces locomotor hyperactivity. [16] [17] [18] and alters the release of extracellular dopamine in the nucleus accumbens. 17 Furthermore, stimulation of a1 receptors can elicit changes in glutamatergic neurons in the prefrontal cortex which, directly or indirectly, can lead to increases in dopamine release, thereby altering both locomotor activating and reinforcing properties of drugs. 17 Noradrenergic neurons are widely distributed throughout the central nervous system, and their associated receptors are equally diverse. The adrenergic receptor gene family has nine members: three b (b1, b2, b3) and six a (a1a, b, d and a2a, b, c) receptor genes. Most of these receptor subtypes are expressed in the brain and much of the work describing distribution and regulation of b and a2 subtypes in the CNS have been achieved through the use of selective receptor agonists and antagonists. However, in the case of the three a1 receptors, this descriptive work has been hampered by the lack of highly specific ligands to differentiate receptor subtypes.
Gene targeting is a powerful approach to investigate gene function in vivo. This technique has been applied to a number of adrenergic receptors (AR) including the b1, b2, b3, a2a, a2b, a2c, a1a/c and a1b. [19] [20] [21] [22] [23] [24] [25] Analysis of these receptor knockout mice has enabled investigators to assign specific functions to certain receptor subtypes. The main advantage of the gene-targeting method for a1 receptor analysis lies in its circumvention of nonspecific pharmacological compounds and drugs which may not readily cross the blood-brain barrier, such as prazosin. 26, 27 To date, two of the three subtypes of a1 receptors, a1a/c 22 and a1b
21
, have been disrupted by gene targeting. Therefore, in order to characterize the functional contribution of the remaining a1d receptors in vivo, we generated mice homozygous for a null allele of the a1d receptor. The data presented here indicate that a1d receptors are dispensable for normal development and physiology as indicated by the production of viable adult mice. However, these receptors appear to be critical in mediating the switch from basal locomotor behavior to an activated state in response to both environmental and specific drug-induced cues.
Materials and methods

Generation of a1d
À/À mouse The mouse a1d gene was cloned from a 129SvJ BAC library (Research Genetics, Inc., Huntsville, AL, USA). The targeting vector containing the Escherichia coli lacZ gene encoding b-galactosidase and the neomycin-resistance gene driven by the mouse phosphoglycerate kinase promoter (pHM4) 28 was inserted into exon 1. Mouse 129SvTac embryonic stem (ES) cells (a gift of Dr P Labosky, University of Pennsylvania) were electroporated and selected for neomycin resistance, and five out of 198 clones were correctly targeted as indicated by Southern blot analysis. Targeted ES cells were injected into C57Bl/6 blastocysts to obtain five germ line chimeras. Heterozygote mice were mated to give rise to mice of all three genotypes, which were genotyped by PCR with a common 5 0 primer (5 0 -CCGCTACTAGGTTGGAAG-GAA-3 0 ) and specific 3 0 primers derived from exon 1 (5 0 -CACGACGATGGCTAGGGTCTT-3 0 ) for the wildtype allele and the neomycin-resistance gene (5 0 -GCCTTCTTGACGAGTTCTTCT-3 0 ) for the mutant allele.
RNA isolation and RNAse protection assays Total RNA was isolated by acid-phenol extraction after homogenization in guanidimium thiocyanate. 29 The quality of the RNA samples was determined by ethidium bromide staining of 18S and 28S ribosomal RNAs after fractionation on denaturing agarose gels. Ribonuclease protection analysis was performed as described previously, 30 using a 190 bp subclone of the mouse a1d cDNA and a 150 bp subclone of the mouse TATA binding protein (TBP) gene 31 as an internal control. Briefly, 32 P UTP-labeled antisense probes were hybridized overnight at 561C against 20 mg hippocampus RNA in 80% formamide. After hybridization, excess probes were digested with RNAses A and T1. Protected probe-mRNA hybrids were separated on denaturing 6% polyacrylamide gels. Signals were quantified and normalized to TBP using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA).
Radioligand binding
Mouse frontal cortex and hippocampus were dissected and frozen in liquid nitrogen for storage at À801C until use. The tissues were briefly homogenized in 10-15 ml cold Tris buffer (10% sucrose in 0.5 mM EDTA and 50 mM Tris HCl, pH 7.7). The homogenate was centrifuged at 48 000 g for 10 min at 41C. The pellet was suspended in Tris buffer and recentrifuged. The resulting pellet was resuspended in Tris Buffer without sucrose to 2.5-2.8 mg of tissue per assay tube. Tissue was incubated for 45 min with 3 H-prazosin at room temperature. Nonspecific binding was determined in the presence of 10 mM phentolamine. The reaction was terminated by rapid filtration through GF/C filters (Whatmann/Brandel) saturated with 0.1% polyethyleneimine. The filters were transferred to vials with scintillation fluid and counted by liquid scintillation spectrometry. Saturation analyses were carried out using 0.03-0.9 nM 
Rotarod
Mice were placed on a rotating rod (Ugo, Basile) uniformly accelerating from 4 to 40 rpm in 5 min. Latency to fall onto the trip plates, which were connected to an LCD timer, was recorded. Mice were given three trials with 60 min intertrial intervals.
Morris water maze
The water maze apparatus consisted of a circular pool (1.2 m diameter) divided into four quadrants of equal size and filled with opaque water. The invisible platform was located in the middle of one of the quadrants 0.7 cm below the surface. The platform position changed between subjects, but remained constant for each animal during the training period. Each mouse was given a block of four trials per day for 9 consecutive days. Each of the four cardinal points (North, East, West and South) was used as the starting a1d Receptor and locomotor activity A Sadalge et al location once within each block. Mice were allowed to swim for a maximum of 60 s and allowed to remain on the platform for a maximum of 30 s. During the probe trial, the platform was removed from the pool and the subject's swimming behavior was observed. Latency, distance, swimming path to find the platform and percent time in quadrant were recorded and analyzed using a tracking system (HVS Image, UK).
Fear conditioning
Mice were trained in a rectangular (16 00 length Â 6 00 width Â 8 00 height) fear conditioning chamber (Med Associates) for 2 min before the onset of the conditioned stimulus (CS; white noise at 85-dB intensity) that lasted for 30 s. The last 2 s of the CS were paired with a single unconditioned stimulus (US; 1.5-mA footshock for 2 s) that ended with the noise and shock coterminating. Mice remained in the chamber for 30 s. Conditioning was assessed by measuring freezing behavior in intervals of 5 s. Contextual conditioning was assessed for 5 consecutive minutes in the chamber in which the mice were trained 24 h after training. Cued conditioning was assessed by placing the mice in a novel context that differed in color, shape, and odor for 2 min (pre-CS test) after which they were exposed to the CS for 3 min (CS test), an hour after the end of the contextual conditioning test.
Wheel-running activity
Mice were housed in cages equipped with 12-cm diameter stainless-steel running wheels (Lab Products, Inc., Maywood, NJ, USA) and monitored for 5-7 days in 12 : 12 light : dark (L : D) to assess rest/ activity behavior and entrainment. Subsequently, activity was monitored in constant darkness for 3 weeks to evaluate the circadian period of locomotor activity (t DD ), length of the active phases (a) and amplitude of circadian periodicity as determined by Fast-Fourier transform (FFT) analysis. Data were collected using an IBM computer-based data acquisition system and analyzed with the Circadia and Biological Rhythms Software. 32 FFT was analyzed using Clocklab with the circadian peak expressed as a relative power of the entire curve normalized to 1.
Locomotor activity
Locomotor activity was analyzed using an activity monitoring system from MED Associates (VT). For testing in a novel environment, mice were removed from their home cage and placed individually in a different testing cage. The testing cage was placed in a photobeam frame (30 Â 24 Â 8 cm) with two levels of sensors arranged in an 8-beam array strip with 1.25 00 spacing. Beam break data were read into MED PC designed software and monitored at 5 min intervals. All experiments were conducted during the light period.
Administration of drugs
Mice were injected with D-amphetamine (2 mg/kg NIDA Drug Supply) 10 min prior to placing them in the activity monitoring cages. Mice were injected with cocaine (20 mg/kg) (NIDA Drug Supply) and immediately placed in the activity monitoring cages. Respective saline controls were injected at the same time.
Statistical analysis
The radioligand binding data were analyzed using unpaired t-test. The rotarod and locomotor activity data were analyzed with repeated measures ANOVAs, using Bonferroni-Dunn post hoc tests in StatView . Morris water maze data were collected using the HVS Image System, UK. Training and probe session data were analyzed using repeated measures and two-way ANOVAs, respectively. Wheel-running and circadian data were collected and analyzed with the Circadia and Biological Rhythms Software. 32 FFT was analyzed using Clocklab with the circadian peak expressed as a relative power of the entire curve normalized to 1.
Results
A null allele of the a1d receptor gene was constructed by inserting a lacZ-neomycin cassette into Exon1, thereby disrupting the ligand binding as well as G protein coupling domains (Figure 1a ). The targeting construct was electroporated into mouse embryonic stem cells, and of 198 G418-resistant colonies analyzed, five had undergone homologous recombination (Figure 1b) . Mice carrying the a1d mutant allele (a1d þ /À ) were derived by blastocyst injection and mated to homozygosity (Figure 1c ). Successful gene ablation was confirmed by RNAse protection analysis, which demonstrated the absence of a1d mRNA in the a1d mutant mice (Figure 1d ). RNAse protection assays showed similar levels of a1a and a1b mRNA in wild-type and a1d À/À mice, indicating the lack of compensatory upregulation of these a1 adrenoceptor genes (data not shown). In addition, 3 H-prazosin binding revealed a significant decrease in B max values in a1d À/À mice in both cortex (15%) and hippocampus (26%) compared to their wild-type littermates (Table  1 ; Po0.05, unpaired t-test). a1d À/À mice showed normal growth and development and were produced with the expected Mendelian frequency of 25%. They performed similar to wild-type mice on a variety of baseline behavior tasks including the rotarod test, indicating an absence of general motor deficits (Table  2 ; F 5,75 ¼ 1.323, P ¼ 0.26).
The presence of the lacZ cDNA in the targeted allele allowed us to follow the expression of the a1d gene by immunohistochemical detection of b-galactosidase. As shown in Figure 2 , the a1d gene is expressed at high levels in the olfactory bulb (Figure 2a Figure 2g and h shows the observed staining on representative plates adapted from The Mouse Brain Atlas. 33 The staining pattern observed in a1D þ /À mice was identical in distribution, albeit weaker in intensity that the a1d Receptor and locomotor activity A Sadalge et al one shown here for the a1D À/À mice. No staining was seen in a1D þ / þ littermate controls (data not shown). Based on the relatively high level of expression of the a1d gene in the hippocampus, we assessed the performance of the mutant mice in tasks that gauge learning and memory deficits. There were no differences in the performance of the a1d À/À mice in the Morris water maze (Figure 3 ). Both the wild-type and the mutant mice show similar decreases in latency to find hidden platform during the training (F 1,206 ¼ 0.047, P40.050). In addition, during the probe session, both groups spent similar amounts of time in the target quadrant (F 1,21 ¼ 1.236, P40.05) and made similar crosses through the position of the hidden platform (F 1,21 ¼ 0.033). To test deficits in emotional learning, fear conditioning was assessed in the a1d À/À mice. However, no differences were seen in the cued or contextual conditioning fear conditioning (Table 3) . Together, these data suggest that the a1d receptors play no essential roles in learning and memory.
The noradrenergic system has been strongly implicated in arousal and sleep-wake functions. In particular, activity of norepinephrine containing neurons in the locus coeruleus is temporally correlated to EEG and behavioral indices of arousal such that activity is increased during waking and decreased during sleep periods. [34] [35] [36] To gauge the effect of a mutation in the a1d receptor on arousal, we evaluated rest : activity behavior by measuring wheel running in light : dark (L : D) and dark : dark (D : D) conditions over the course of a 24 h sleep-wake cycle. Mutant mice showed significant decreased wheelrunning activity when compared with the wild-type mice 2 h after onset of the dark period for the duration of 6 hours (Figure 4a ) (Two-sample t-test; Po0.01). These patterns were analyzed in D : D conditions to Membranes from tissues of mice aged 14-18 weeks were used in binding reactions with 3 H-prazosin. Specific binding was determined using 10 mM phentolamine. Values are from four to five mice of each genotype. *Po0.05 compared to WT (unpaired t-test). Mice were placed on a rotating rod 16 cm above a platform with trip plates. They were given three trials with 60 min intertrial intervals. Latency to fall off within 5 min was recorded. Values are from 13 to 14 mice of each genotype (P>0.05 not significant ANOVA).
a1d Receptor and locomotor activity A Sadalge et al determine if there were alterations in circadian period (t DD ), the length of the activity phase (a) and strength of circadian periodicity as measured by FFT analysis. However, no significant differences were found between wild-type and mutant mice (Figure 4b ). Taken together, these data indicate a specific attenuation of locomotion in response to the onset of the dark period in the a1d À/À mice that is unrelated to changes in circadian rhythmicity.
Pharmacological studies have identified a positive role for norepinephrine in active behavior, with most a1 agonists increasing, 7, 37, 38 and most a1 antagonists decreasing 16, 39, 40 activity. Therefore, we assessed locomotor activity in response to a novel cage environment. As shown in Figure 5a , activity associated with rearing behavior is significantly decreased in a1d À/À mice when compared to their wild-type littermates (F (1, 22) ¼ 0.2526; P ¼ 0.0068, post hoc test). This reduction is maintained throughout the 30-min test session. In contrast, ambulatory activity is not significantly different between the two groups ( Figure  5b , F (1, 22) ¼ 0.332; P ¼ 0.5706, ANOVA). Taken together, these data indicate that ambulations and rears may be regulated independently of each other and that a1d receptors have a specific role in mediating responses associated with rearing behavior and not general ambulatory activity in the light period. Pharmacological blockade of a1 receptors in general has implicated these subtypes in mediating locomotor responses to psychomotor stimulants. To assess Mice were subjected to 1.5 mA shock for 30 s, 2 min after placing them in the conditioning chamber. Amount of freezing was scored in a similar context or with a salient cue 24 h after conditioning. Values are from 11 to 12 mice of each genotype (P>0.05 not significant ANOVA).
a1d Receptor and locomotor activity A Sadalge et al whether the action of the stimulants is dependent on a1d adrenoceptors specifically, we examined the response to acute administration of D-amphetamine and cocaine in wild-type and a1d À/À mice. Mutant mice treated with amphetamine (2 mg/kg) showed no increase in locomotor activity following drug administration (Figure 6a ) (F (3,42) ¼ 1.602; not significant). This is in contrast to the wild-type mice that showed a significant increase in locomotion when compared with both the wild-type saline-treated group and the mutant amphetamine treated group (F (3,42) ¼ 1.602; Po0.0002 from saline group and mutant amphetamine group). In order to investigate the specificity of the observed locomotor phenotype, the response of the mutant mice to another psychostimulant, cocaine, was measured. Both wild-type and mutant mice treated with cocaine (20 mg/kg) showed significant increased ambulatory activity when compared with their saline controls (Figure 6b ) (F (3, 27) ¼ 2.458; Po0.005 from saline groups). Together, these data demonstrate the specific requirement for a1d receptors to enhance amphetamine, but not cocaineinduced locomotor effects.
Discussion
In these studies, we describe the inactivation of the a1d adrenergic receptor through gene targeting. RNAse protection assays show the specific absence of a1d mRNA, while the levels of a1a and a1b mRNA were found to be similar in mutant and wild-type mice. Therefore, it is unlikely that any of the observed behavioral phenotypes in a1d À/À mice are because of compensation by other a1 receptors. Additional adaptive changes occurring during the development of the a1d mutant mice cannot be ruled out; however, this caveat applies to all studies with genetically altered organisms. In addition, 3 H-prazosin binding reveals a reduction in B max in the cortex and the hippocampus regions of the a1d À/À mice when compared with the wild-type mice. This modest decrease reflects the specific loss of a1d receptors in the a1d À/À mice, while remaining 3 H-prazosin binding in these mice reflects a1a and a1b receptors, which are not altered. The a1d À/À mice generated exhibit normal growth and do not show tests general motor deficits as evidenced by their normal performance on the rotarod test.
The presence of the a1d receptor mRNA was previously noted in the hippocampus, cortex and in Figure 4 Wheel-running activity and circadian rhythms in a1D þ / þ and a1D À/À mice. (a) Wheel-running activity as a function of subjective time (Zeitgeber time or ZT). Mutant mice (n ¼ 12) show attenuated wheel-running activity 2 h after the onset of the dark period for a period of 6 h when compared with wild-type mice (n ¼ 12). There is no significant difference in wheel-running activity in the light period. (b) Changes in circadian rhythms between wild-type and mutant mice under D : D conditions. There is no significant difference between the wild-type or mutant mice with respect to circadian period (t), length of activity phase (a) or strength of circadian periodicity (power FFT). 41, 42 Our data reveal the expression pattern in greater detail. Although, a1d mRNA has been observed in the hippocampus, our data show that it is highly expressed in the CA1 and CA3 regions of the hippocampus, but is absent in the superior blade of the dentate gyrus.
Although the lac-Z staining indicates that a1d receptors are expressed in high levels in the hippocampus, we found no differences in spatial and emotional learning as assessed by the Morris water maze and through cued and contextual fear conditioning. This suggests that a1d receptors are not critical for learning and memory processes. These data are in agreement with previous studies that indicate a minimal role of a1 receptors in mediating synaptic transmission in the hipocampus. 43 However, stimulation of a1 receptors in the hippocampus has been shown to cause behavioral activation in rats. 44 The lack of behavioral activation observed in several paradigms tested in a1d À/À mice suggests that a1d receptors in the hippocampus of the mouse may be required for this response.
In addition to the high density of a1d receptors in the hippocampus, there is also a high concentration of these receptors in the cortex and olfactory bulb. Furthermore, the presence of a1d receptors in the dorsal and ventral lateral geniculate nuclei of the thalamus was previously not described. Moreover, the thalamus is implicated as a site for noradrenergic gating of sensory input as well as arousal. 45 Hence, the presence of a1d receptors in these areas may be responsible for normal responses to stimuli and subsequent behavioral activation, which is absent in a1d À/À mice. Other areas of the brain involved in basal motor activity, such as the posterior hypothalamus and brainstem reticular activating system, are also innervated by noradrenergic projections, and a1 receptors have been localized to these regions via receptor autoradiography. 46, 47 However, the present data indicate that these areas are devoid of a1d receptors, supporting the finding that basal motor activity is not mediated through a1d receptors.
A variety of pharmacological studies have found a positive role for norepinephrine in active behavior. Monitoring of rest : activity cycles in the mouse can be accomplished with wheel-running activity. In this paradigm, mice spend a significant portion of their 'active' phase running on wheels. In the light : dark cycle, wheel-running activity reflects an animal's synchronization to exogenous cues, whereas wheel running in constant darkness allows for the determination of circadian period. 48 In this paradigm, a1d
À/À mice show decreased activity 2 h after onset of the dark period, exactly the time period when their wildtype littermates show increasing wheel-running behavior. Alterations in diurnal locomotor activity could be because of an underlying circadian rhythm deficit. The noradrenergic system has been implicated in sleep-wake functions, and more recently in neuronal circuits for circadian regulation of arousal. 34 However, mice lacking a1d receptors do not have altered circadian rhythms as demonstrated by equivalent circadian period (t DD ), the length of the activity phase (a) and strength of circadian periodicity (FFT). Hence, the ability to react to a change in environmental conditions, namely the light : dark cycle, appears to be dependent on a1d receptors. Alterations in noradrenergic activity have been shown to affect reactivity to novel environments. Activation of the noradrenergic system with a2 receptor antagonists increases the amount of time spent exploring new objects in a familiar environment. 49 In contrast, peripheral administration of a1 antagonists has been shown to reduce exploratory activity stimulated by novelty. 16, 40 In addition, recent studies have shown a high correlation between the pharmacological blockade of central a1 receptors and the inhibition of behavioral activity in a mildly novel environment. 27 The present data indicate that reactiv- Figure 6 Locomotor response to administration of psychomotor stimulants in a1d þ / þ and a1d À/À mice. (a) Acute locomotor response to amphetamine (2 mg/kg). Mutant mice (n ¼ 13) showed no significant increase in locomotor activity following drug administration (F (3,42) ¼ 1.602; not significant from saline group). Wild-type mice treated with amphetamine (n ¼ 13) showed a significant increase in locomotion when compared with the wild-type salinetreated group (n ¼ 10), or the amphetamine-treated mutant group (F (3,42) ¼ 1.602; Po0.0002 from saline group and mutant amphetamine group). Data are reported as mean7SEM. (b) Acute locomotor response to cocaine (20 mg/kg). Both wild-type and mutant mice treated with cocaine (n ¼ 7 each) show significantly increased ambulatory activity when compared with their saline counterparts (n ¼ 8-9) (F (3,27) ¼ 2.458; Po0.005 from saline groups). There is no significant difference between the wild-type and mutant animals in either group (F (3,27) ¼ 2.458; not significant).
a1d Receptor and locomotor activity A Sadalge et al ity in a novel environment is significantly reduced in a1d À/À mice. This is in stark contrast to a1b À/À mice that show enhanced reactivity to new situations. 50 While the behavioral paradigms, assessing novel reactivity in a1b À/À , were different from those used in the present study, the contrasting data suggest specific functions for subtypes of a1 adrenergic receptors in mediating behavioral reactivity.
Psychomotor stimulants such as amphetamine and cocaine block the reuptake of catecholamines and increase the amount of extracellular neurotransmitter in the synapse. 51 While dopamine is considered the primary neurotransmitter responsible for behavioral effects of these drugs, norepinephrine also plays an important role [52] [53] [54] and interactions among these two systems have been described. For example, dopaminergic neurotransmission is enhanced by activation of a1 adrenergic receptors, 7, 16, 40 whereas the infusion of prazosin, a non subtype selective antagonist, leads to attenuation of hyperlocomotion after amphetamine administration. 17 The absence of a1d receptors in mice also leads to attenuation of hyperlocomotion after amphetamine administration. However, this response is not extended to other psychomotor stimulants, such as cocaine. Locomotor activity following acute cocaine administration is the same for both a1d À/À mice and their wild-type littermates. This is in contrast to a1b À/À mice that show a decrease in locomotion after administration of either D-amphetamine or cocaine. 55 These data would suggest that, while alterations in locomotor activity in response to cocaine are modulated by a1b receptors, responses to amphetamine may be influenced by both a1b and a1d receptors. In addition, mice lacking the a1b adrenergic receptor show decreases in the rewarding properties of drugs of abuse such as amphetamine as well as morphine. 55 However, the a1d mutant mice show normal place conditioning to amphetamine, morphine and cocaine (Walters, Sadalge and Blendy, unpublished results). This phenotype is further supported by the lack of expression of a1d receptors in the nucleus accumbens or the ventral tegmental area, areas of the brain associated with rewarding properties of drugs of abuse. Therefore, it is clear that the a1d receptors play an important role in specifically mediating the locomotor responses to and not the rewarding effects of amphetamine administration.
Adrenergic receptors play key roles in the modulation of CNS activity; however, the functional characterization of the a1 receptors has lagged behind other adrenergic family members. The utilization of gene targeting can infer function of specific genes through evaluation of phenotypes. The present study takes advantage of this genetic approach to investigate the function of the a1d receptor gene. Additionally, the insertion of a reporter gene, lacZ, in the targeting vector allows us to follow more precisely the anatomical location of the a1d receptor gene. Together, these data have identified a role for a1d receptors in mediating behavioral activation and suggest that these receptors are important for facilitating selective attention to environmental cues. The development of a1d subtype-selective agonist may have therapeutic value in the treatment of generalized attention-deficit disorders.
